Insider track record Other Across 32 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Victoria Whyte. Insider active across 1 company, notably GSK plc. Aggregated, 95 reports have been published. Activity tracked since 9 August 2023. The latest transaction was disclosed on 9 June 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Declarations 95 total
● SVP & Company Secretary · Executives · 9 Jun 2026 · GSK plc 12 shares @ £18.8392 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:9614374-7 Ideal exit: 6 Mar 2027 (T+270) ● SVP & Company Secretary · Executives · 9 Jun 2026 · GSK plc 12 shares @ £18.8392 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:03338973-0058-4811-9fe5-7b22157346a2-7 Ideal exit: 6 Mar 2027 (T+270) ● SVP & Company Secretary · Executives · 12 May 2026 · GSK plc 14 shares @ £18.6557 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:eaad27f1-a91f-4bc4-815a-149202956de0-7 Ideal exit: 6 Feb 2027 (T+270) ● SVP & Company Secretary · Executives · 13 Apr 2026 · GSK plc 12 shares @ £21.7083 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:bae2311e-28b0-4835-a894-0209eedccba9-7 Ideal exit: 8 Jan 2027 (T+270) ● SVP & Company Secretary · Executives · 10 Apr 2026 · GSK plc 15 shares @ £21.696 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:66208821-3d67-43ba-837e-411f45d449f1-1 Ideal exit: 5 Jan 2027 (T+270) ● SVP & Company Secretary · Executives · 9 Apr 2026 · GSK plc 52 shares @ £21.3387 0.0000% mcap 0.1% of flow GB00BN7SWP63⌘ RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-8 Ideal exit: 4 Jan 2027 (T+270) ● SVP & Company Secretary · Executives · 9 Apr 2026 · GSK plc 208 shares @ £21.5039 0.0000% mcap 0.2% of flow GB00BN7SWP63⌘ RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-10 Ideal exit: 4 Jan 2027 (T+270) ● SVP & Company Secretary · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow GB00BN7SWP63⌘ RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-7 Ideal exit: 5 Dec 2026 (T+270) ● SVP & Company Secretary · Executives · 13 Feb 2026 · GSK plc 10,908 shares 0
GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-26 ● SVP & Company Secretary · Executives · 13 Feb 2026 · GSK plc 5,127 shares @ £21.6002 5.9% of flow GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-27 ● SVP & Company Secretary · Executives · 12 Feb 2026 · GSK plc 11,800 shares @ £21.41 13.4% of flow GB00BN7SWP63⌘ RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-14 ● SVP & Company Secretary · Executives · 9 Feb 2026 · GSK plc 10,050 shares 0
GB00BN7SWP63⌘ RNS:b9b234f0-beb3-4926-b79e-ff2ce727c5dd-8 ● SVP & Company Secretary · Executives · 9 Feb 2026 · GSK plc 4,724 shares @ £21.9082 5.5% of flow GB00BN7SWP63⌘ RNS:b9b234f0-beb3-4926-b79e-ff2ce727c5dd-9 ● SVP & Company Secretary · Executives · 10 Feb 2026 · GSK plc 10 shares @ £21.792 0.0% of flow GB00BN7SWP63⌘ RNS:f7024c14-f781-4e48-a904-495085bc7ca2-7 Ideal exit: 7 Nov 2026 (T+270) ● SVP & Company Secretary · Executives · 9 Jan 2026 · GSK plc 15 shares @ £18.8453 0.0% of flow GB00BN7SWP63⌘ RNS:111c1f6b-b3ce-4885-be8f-52a82b2acf50-1 Ideal exit: 6 Oct 2026 (T+270) ● SVP & Company Secretary · Executives · 8 Jan 2026 · GSK plc 52 shares @ £18.9433 0.1% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-9 Ideal exit: 5 Oct 2026 (T+270) ● SVP & Company Secretary · Executives · 8 Jan 2026 · GSK plc 109 shares @ £18.9464 0.1% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-22 Ideal exit: 5 Oct 2026 (T+270) ● SVP & Company Secretary · Executives · 12 Jan 2026 · GSK plc 14 shares @ £18.9321 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-49 Ideal exit: 9 Oct 2026 (T+270) ● SVP & Company Secretary · Executives · 2 Jan 2026 · GSK plc 790 shares @ £11.39 0.5% of flow GB00BN7SWP63⌘ RNS:d1d365d8-4abe-41af-91cd-f67c2fcdf8a4-1 Ideal exit: 29 Sept 2026 (T+270) ● SVP & Company Secretary · Executives · 9 Dec 2025 · GSK plc 14 shares @ £18.0779 0.0% of flow GB00BN7SWP63⌘ RNS:58b71e9c-e0b4-4fdd-8b21-5f1119d38ddd-8 Ideal exit: 5 Sept 2026 (T+270) ● SVP & Company Secretary · Executives · 28 Nov 2025 · GSK plc 643 shares @ £14.19 0.5% of flow GB00BN7SWP63⌘ RNS:0ba74213-2a39-4226-8c3a-7a678946c4c7-2 ● SVP & Company Secretary · Executives · 11 Nov 2025 · GSK plc 14 shares @ £18.1421 0.0% of flow GB00BN7SWP63⌘ RNS:802a4789-60c0-4a7f-a34b-b750f1d9f048-8 Ideal exit: 8 Aug 2026 (T+270) ● Company Secretary · Executives · 10 Oct 2025 · GSK plc 17 shares @ £16.35 0.0% of flow GB00BN7SWP63⌘ RNS:5862277-14 Ideal exit: 7 Jul 2026 (T+270) ● SVP & Company Secretary · Executives · 9 Oct 2025 · GSK plc 58 shares @ £16.3921 0.1% of flow GB00BN7SWP63⌘ RNS:5859068-9 Ideal exit: 6 Jul 2026 (T+270) ● SVP & Company Secretary · Executives · 9 Oct 2025 · GSK plc 0
GB00BN7SWP63⌘ RNS:5859068-24 Ideal exit: 6 Jul 2026 (T+270) 25 of 95 declarations
Load more (70 remaining) About Victoria Whyte Victoria Whyte is a declarant who has made 95 filings in total. In her most recent filings, she has executed a total purchase of 49,153 EUR and a total sale of 505,730 EUR, with the first filing dated July 31, 2023, and the last expected on June 12, 2026. The most significant transactions include an amount of 289,790.95 EUR on February 16, 2026, and 231,260.61 EUR on February 12, 2024.